Please wait while the formulary information is being retrieved.
FLOXURIDINE (floxuridine)
- Malignant neoplasm of liver
- Primary malignant neoplasm of gastrointestinal tract
0.5 gram solution for injection
- Dosage information is not available
- adenovirus vac live type-4 & 7
- adenovirus vaccine live type-4
- adenovirus vaccine live type-7
- BCG vaccine, live (PF)
- flu vac,qval 2013-14 (2-49yrs)
- Flumist 2013-2014
- M-m-r Ii (pf)
- measles,mumps&rubella vacc(PF)
- measles,mumps,rub,varicel(PF)
- natalizumab
- Proquad (pf)
- Rotateq Vaccine
- rotavirus vaccine live, penta
- typhoid vaccine
- Tysabri
- varicella virus vacc live (PF)
- Varivax (pf)
- Vivotif Berna Vaccine
- yellow fever vaccine live (PF)
- Yf-vax (pf)
- Zostavax (pf)
- zoster vaccine live (PF)
Contraindicated
- None
Severe
Moderate
- None
- Bone marrow depression
- Esophagitis
- Gastrointestinal hemorrhage
- Gastrointestinal ulcer
- Lactating mother
- Leukopenia
- Myocardial ischemia
- Persistent vomiting
- Pharyngitis
- Protein-calorie malnutrition
- Severe infection
- Stomatitis
- Thrombocytopenic disorder
Contraindicated
- Abnormal hepatic function tests
- Anemia
- Biliary sclerosis
- Cholecystitis
- Disease of liver
- Hemorrhage
- Hyperbilirubinemia
- Kidney disease with reduction in GFR
- Pregnancy
Severe
Moderate
- None
FLOXURIDINE (floxuridine)
- Malignant neoplasm of liver
- Primary malignant neoplasm of gastrointestinal tract
- Aphthous stomatitis
- Gastroenteritis
- None
More Frequent
Severe
Less Severe
- Erythema
- Esophagitis
- Gastritis
- Gastrointestinal ulcer
- Glossitis
- Nausea
- Pharyngitis
- Skin scaling of feet
- Skin scaling of hands
- Vomiting
- Alopecia
- Anorexia
- Pruritus of skin
- Skin rash
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Anemia
- Biliary sclerosis
- Cholecystitis
- Drug-induced hepatitis
- Gait abnormality
- Infection
- Jaundice
- Leukopenia
- Thrombocytopenic disorder
Less Severe
- None
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
None
Floxuridine
- Severity Level:
D
- Additional Notes:
Contraindicated
Floxuridine
Not recommended;Potential severe adverse effects
General | Excretion Potential | Effect on Infant | Notes |
Drug should not be given to breast feeding mothers | Unknown | Not known; no or inclusive data | Not recommended;Potential severe adverse effects |
Precaution Exists
None
General | Excretion Potential | Effect on Infant | Notes |
None |
No Known Risk
None
General | Excretion Potential | Effect on Infant | Notes |
None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
Malignant neoplasm of liver | |
C22 | Malignant neoplasm of liver and intrahepatic bile ducts |
C22.0 | Liver cell carcinoma |
C22.1 | Intrahepatic bile duct carcinoma |
C22.2 | Hepatoblastoma |
C22.3 | Angiosarcoma of liver |
C22.4 | Other sarcomas of liver |
C22.7 | Other specified carcinomas of liver |
C22.8 | Malignant neoplasm of liver, primary, unspecified as to type |
C22.9 | Malignant neoplasm of liver, not specified as primary or secondary |
Primary malignant neoplasm of gastrointestinal tract | |
C16 | Malignant neoplasm of stomach |
C16.0 | Malignant neoplasm of cardia |
C16.1 | Malignant neoplasm of fundus of stomach |
C16.2 | Malignant neoplasm of body of stomach |
C16.3 | Malignant neoplasm of pyloric antrum |
C16.4 | Malignant neoplasm of pylorus |
C16.5 | Malignant neoplasm of lesser curvature of stomach, unspecified |
C16.6 | Malignant neoplasm of greater curvature of stomach, unspecified |
C16.8 | Malignant neoplasm of overlapping sites of stomach |
C16.9 | Malignant neoplasm of stomach, unspecified |
C17 | Malignant neoplasm of small intestine |
C17.0 | Malignant neoplasm of duodenum |
C17.1 | Malignant neoplasm of jejunum |
C17.2 | Malignant neoplasm of ileum |
C17.3 | Meckel's diverticulum, malignant |
C17.8 | Malignant neoplasm of overlapping sites of small intestine |
C17.9 | Malignant neoplasm of small intestine, unspecified |
C18 | Malignant neoplasm of colon |
C18.0 | Malignant neoplasm of cecum |
C18.1 | Malignant neoplasm of appendix |
C18.2 | Malignant neoplasm of ascending colon |
C18.3 | Malignant neoplasm of hepatic flexure |
C18.4 | Malignant neoplasm of transverse colon |
C18.5 | Malignant neoplasm of splenic flexure |
C18.6 | Malignant neoplasm of descending colon |
C18.7 | Malignant neoplasm of sigmoid colon |
C18.8 | Malignant neoplasm of overlapping sites of colon |
C18.9 | Malignant neoplasm of colon, unspecified |
C19 | Malignant neoplasm of rectosigmoid junction |
C20 | Malignant neoplasm of rectum |
C26.0 | Malignant neoplasm of intestinal tract, part unspecified |
0-9 | A-Z |
---|---|
C16 | Malignant neoplasm of stomach |
C16.0 | Malignant neoplasm of cardia |
C16.1 | Malignant neoplasm of fundus of stomach |
C16.2 | Malignant neoplasm of body of stomach |
C16.3 | Malignant neoplasm of pyloric antrum |
C16.4 | Malignant neoplasm of pylorus |
C16.5 | Malignant neoplasm of lesser curvature of stomach, unspecified |
C16.6 | Malignant neoplasm of greater curvature of stomach, unspecified |
C16.8 | Malignant neoplasm of overlapping sites of stomach |
C16.9 | Malignant neoplasm of stomach, unspecified |
C17 | Malignant neoplasm of small intestine |
C17.0 | Malignant neoplasm of duodenum |
C17.1 | Malignant neoplasm of jejunum |
C17.2 | Malignant neoplasm of ileum |
C17.3 | Meckel's diverticulum, malignant |
C17.8 | Malignant neoplasm of overlapping sites of small intestine |
C17.9 | Malignant neoplasm of small intestine, unspecified |
C18 | Malignant neoplasm of colon |
C18.0 | Malignant neoplasm of cecum |
C18.1 | Malignant neoplasm of appendix |
C18.2 | Malignant neoplasm of ascending colon |
C18.3 | Malignant neoplasm of hepatic flexure |
C18.4 | Malignant neoplasm of transverse colon |
C18.5 | Malignant neoplasm of splenic flexure |
C18.6 | Malignant neoplasm of descending colon |
C18.7 | Malignant neoplasm of sigmoid colon |
C18.8 | Malignant neoplasm of overlapping sites of colon |
C18.9 | Malignant neoplasm of colon, unspecified |
C19 | Malignant neoplasm of rectosigmoid junction |
C20 | Malignant neoplasm of rectum |
C22 | Malignant neoplasm of liver and intrahepatic bile ducts |
C22.0 | Liver cell carcinoma |
C22.1 | Intrahepatic bile duct carcinoma |
C22.2 | Hepatoblastoma |
C22.3 | Angiosarcoma of liver |
C22.4 | Other sarcomas of liver |
C22.7 | Other specified carcinomas of liver |
C22.8 | Malignant neoplasm of liver, primary, unspecified as to type |
C22.9 | Malignant neoplasm of liver, not specified as primary or secondary |
C26.0 | Malignant neoplasm of intestinal tract, part unspecified |
Formulary Reference Tool